|
Volumn 363, Issue 9404, 2004, Pages 249-
|
Lyme borreliosis [10]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
BACTERIAL ANTIGEN;
BACTERIAL DNA;
ANTIBIOTIC THERAPY;
B CELL LEUKEMIA;
B CELL LYMPHOMA;
BACTERIUM DETECTION;
BORRELIA BURGDORFERI;
CANCER INVASION;
CELL INFILTRATION;
CLINICAL FEATURE;
DNA DETERMINATION;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HUMAN;
IMMUNOHISTOCHEMISTRY;
IMMUNOSTIMULATION;
LETTER;
LYME DISEASE;
LYMPHOCYTOMA;
MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA;
PATHOGENESIS;
PRIORITY JOURNAL;
REMISSION;
SEROLOGY;
SKIN DISEASE;
SKIN LYMPHOMA;
SKIN MANIFESTATION;
TREATMENT OUTCOME;
UNITED STATES;
COMORBIDITY;
ISOLATION AND PURIFICATION;
MICROBIOLOGY;
NOTE;
SKIN TUMOR;
BORRELIA BURGDORFERI;
COMORBIDITY;
DNA, BACTERIAL;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
LYME DISEASE;
LYMPHOMA, B-CELL;
LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE;
SKIN NEOPLASMS;
|
EID: 1642534425
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(03)15350-0 Document Type: Letter |
Times cited : (3)
|
References (5)
|